2m 2m 2m 2m 2m 2m 2m
Whitehawk (WHWK)
NASDAQ
$4.71-$0.02 (-0.44%)
Price as of Aug 21, 2026 7:31 PM EDT- $269.7MMarket Cap
- 171.84%1-Year Change
- BiotechnologyIndustry
Whitehawk (WHWK)
$4.71-$0.02 (-0.44%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 48
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$4.64
$4.94
$4.73
1-Year Range
$1.70
$5.10
$4.73
Latest Close$4.73
Change
-$0.10 (-2.11%)
Volume226,205
Market Cap$269.7M
Shares Outstanding57.0M
P/E (TTM)-4.30
Diluted EPS (TTM)-$1.10
Enterprise Value$184.4M
Information as of 08/21/2026
Company Profile
WHITEHAWK THERAPEUTICS INC
https://ir.whitehawktx.com$269.7M
Market Cap
-$79.8M
Net Income
Sector: Healthcare
Industry: Biotechnology
2 Headquarters Plaza, Morristown, NJ, United States, 07960
551 321 2234Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Key Executives
- David J. Lennon
- Scott Giacobello
- Bryan Ball
- Neil Desai
- Stephen Rodin
Current Ownership Distribution
- Other27.0M (47.33%)
- Insiders21.3M (37.39%)
- Mutual Funds8.7M (15.28%)
- Institutions0 (0.00%)